Neurotoxicity Assessment Service
Better Protection for the Nervous System
Neurotoxicity is one of the most critical safety concerns in the development of pharmaceuticals, chemicals, and consumer products. Early identification of compounds that may adversely affect the nervous system can prevent costly setbacks and ensure the safety of patients and consumers. Neurotoxicity assessment service at Creative Biolabs provides comprehensive in vitro testing to evaluate the potential neurotoxic effects of new substances. With cutting-edge technology and customized testing protocols, we help you make informed decisions throughout your development process.
Technologies
Our neurotoxicity assessment service employs a variety of advanced methods to evaluate the potential toxic effects on the nervous system, including:
Cell Viability and Cytotoxicity
Neuronal Differentiation and Maturation
Apoptosis Detection
Neuronal Morphology
Neurotransmitter Release
Ion Channel and Synaptic Function
Gene Expression Analysis
Neuroinflammation Assessment
Mitochondrial Damage Detection
Intracellular Oxidative Damage
Neurite Growth Assessment
Electrophysiology
We utilize a wide range of cell models and advanced detection methods to evaluate the potential impact of compounds on the nervous system. Primary neural cells from rats and mice (such as cortex, hippocampus, and dorsal root ganglion) are used alongside established cell lines, including HT22, and PC12 cells (both differentiated and undifferentiated). To assess neurotoxicity, various assays are employed, including cell viability tests (e.g., CTG, CCK-8, LDH, PI/Hoechst), mitochondrial damage detection (JC-1, Mito ROS, Rhod-2-AM), and oxidative stress analysis (H2DCFDA). Additional methods such as neurite growth assessments (MAP-2, Sholl analysis), patch clamp electrophysiology, and multi-electrode array (MEA) testing are used to evaluate neuronal function and morphology.
These detection techniques provide detailed insights into multiple aspects of neurotoxicity, including cell viability, mitochondrial function, oxidative stress, and neuronal communication. The combination of these methods allows for a comprehensive understanding of how compounds interact with the nervous system, helping researchers identify potential toxic effects early in the development process. By integrating cutting-edge technologies, the service enables tailored testing to meet specific needs, ensuring the safety and effectiveness of new drugs, chemicals, and materials.
Advantages
-
Comprehensive Testing
Our service includes a wide range of assays to assess various aspects of neurotoxicity, from cell viability and apoptosis to synaptic function and gene expression changes. -
Early Risk Detection
Our in vitro testing identifies potential neurotoxic effects early in development, enabling you to refine your compounds and avoid long-term safety concerns. -
State-of-the-Art Technology
We utilize cutting-edge techniques, including high-content imaging, patch-clamp electrophysiology, and advanced molecular analysis, to ensure high sensitivity and accuracy in detecting neurotoxic effects. -
Tailored Solutions
We offer customized testing protocols based on your specific compound and target. Whether you're testing small molecules, biologics, or new materials, we adjust our methods to meet your needs.
Applications
Pharmaceuticals
Evaluate the safety of new drug candidates, including small molecules, biologics, and gene therapies, to ensure they do not pose neurotoxic risks to patients.
Nanomaterials
Screen nanoparticles and nanomaterials used in drug delivery, diagnostics, and consumer products to ensure they do not cause neurotoxicity.
Toxicology Research
Investigate the mechanisms behind neurotoxicity to identify potential biomarkers or therapeutic targets for neurodegenerative diseases, such as Alzheimer's or Parkinson's.
Frequently Asked Questions
Q1: What types of cells can be used for neurotoxicity testing?
A1: We use a variety of neuronal cell models, including primary rat or human neurons, neuroblastoma cells, and induced pluripotent stem cell (iPSC)-derived neurons.
Q2: Can I test multiple compounds in one batch?
A2: Yes, we offer high-throughput testing and can accommodate multiple compounds for parallel testing, providing comparative toxicity data.
Q3: Can you assess the long-term effects of compounds on neuronal cells?
A3: Yes, we offer chronic exposure studies to assess the long-term impact of compounds on neuronal health and function.
Q4: How do you measure neuronal toxicity?
A4: We assess toxicity using multiple approaches, including evaluating cell viability, apoptosis, changes in neuronal morphology, neurotransmitter release, gene expression alterations, and neuroinflammation markers.
Q5: What type of compounds can be tested for neurotoxicity?
A5: Our service supports testing of a broad range of compounds, including small molecules, biologics, nanomaterials, and consumer products.
Q6: Can neurotoxicity studies be customized to my specific needs?
A6: We can tailor the testing protocols to address the specific endpoints and conditions relevant to your compound and research goals.
Understanding the neurotoxic potential of your compounds is essential to ensuring their safety and efficacy. If you're looking for reliable, comprehensive neurotoxicity testing to support your product development, we are here to assist. Contact us to discuss how we can tailor our neurotoxicity assessments to your specific needs.
Download our brochure